Glial fibrillary acidic protein (GFAP), Mouse Monoclonal Antibody

As low as US$317.00
Only %1 left
Catalog Number
M-1375

    Product Info

  • Product Name Glial fibrillary acidic protein (GFAP), Mouse Monoclonal Antibody
  • Product Description google Mouse anti-Glial fibrillary acidic protein (GFAP) Monoclonal Antibody (Unconjugated), suitable for WB, IHC-Frozen, ICC.
  • Alternative Names Astrocyte; Glial fibrillary acidic protein; GFAP;
  • Application(s) ICC, IHC-Frozen, WB
  • Antibody Host Mouse
  • Antibody Type Monoclonal
  • Specificity The specificity of this antibody has been confirmed by WB. Human, Rat, Mouse, Bovine, Porcine. Predicted to react with other mammalian and avian species.
  • Species Reactivity Avian (Predicted), Bovine, Human, Mouse, Other Mammals (Predicted), Pig, Rat
  • Immunogen Description Purified GFAP from porcine spinal cord
  • Conjugate Unconjugated
  • Purity Description Protein G purified
  • Regulatory Status For research use only.

    Specifications

  • Product Description Mouse anti-Glial fibrillary acidic protein (GFAP) Monoclonal Antibody (Unconjugated), suitable for WB, IHC-Frozen, ICC.
  • Application(s) ICC, IHC-Frozen, WB
  • Application Details Western Blotting (WB), Immunocytochemistry (ICC) and Immunohistochemistry (IHC). A dilution of 1:5,000 is recommended for WB. Human GFAP has a predicted length of 432 residues and a MW of 50 kDa. A dilution of 1:500-1:1,000 is recommended for ICC/IHC. This antibody works well on frozen sections, cells in tissue culture and on formalin fixed histological sections. Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
  • Target Glial fibrillary acidic protein (GFAP)
  • Specificity The specificity of this antibody has been confirmed by WB. Human, Rat, Mouse, Bovine, Porcine. Predicted to react with other mammalian and avian species.
  • Target Host Species Pig
  • Species Reactivity Avian (Predicted), Bovine, Human, Mouse, Other Mammals (Predicted), Pig, Rat
  • Antibody Host Mouse
  • Antibody Type Monoclonal
  • Antibody Isotype IgG1
  • Clone Name 5C10
  • Conjugate Unconjugated
  • Immunogen Description Purified GFAP from porcine spinal cord
  • Purity Description Protein G purified
  • Format Lyophilized from PBS buffer pH 7.2-7.6 with 0.1% trehalose, and sodium azide
  • Reconstitution Instructions Spin vial briefly before opening. Reconstitute with 100 µL sterile-filtered, ultrapure water to achieve a 1 mg/mL concentration. Centrifuge to remove any insoluble material.
  • Storage Instructions After reconstitution of lyophilized antibody, aliquot and store at -20°C for a higher stability. Avoid freeze-thaw cycles.
  • Batch Number Please see item label.
  • Expiration Date 12 months after date of receipt (unopened vial).
  • Alternative Names Astrocyte; Glial fibrillary acidic protein; GFAP;
  • Uniprot Number Q8WP16
  • Uniprot Number/Name Q8WP16 (Q8WP16_PIG)
  • Scientific Background GFAP is a 50 kDa intra-cytoplasmic filamentous protein of the cytoskeleton in astrocytes. During the development of the central nervous system, it is a cell-specific marker that distinguishes astrocytes from other glial cells. GFAP immunoreactivity has been shown in immature oligodendrocytes, epiglottic cartilage, pituicytes, papillary meningiomas, myoepithelial cells of the breast and in non-CNS: Schwann cells, salivary gland neoplasms, enteric glia cells, and metastasizing renal carcinomas.
  • Shipping Temperature 25°C (ambient)
  • UNSPSC CODE 41116161
  • Regulatory Status For research use only.

    Images, Protocols & SDS

  • Mixed neuron-glial cultures stained with Mouse monoclonal antibody to Glial Fibrillary Acidic Protein [5C10] M-1375-100 (red) and chicken polylclonal antibody to neurofilament L C-1390-50 (green). The GFAP antibody stains the network of astrocytes in these cultures, while the NF-L antibody stains neurons and their processes. The blue channel shows the localization of DNA.

  • Right: Detection of GFAP expression in rat cerebellum by Immunohistochemistry with mouse antibody to GFAP (1:1,000, green), and co-stained with rabbit antibody to NF-L (R-1392-50, 1:2,000, red). IHC Method: Following transcardial perfusion with 4% PFA, brain was post-fixed for 24 hours, cut to 45 um sections, and free-floating sections were stained. Clone 5C10 stains a network of astroglial cells, while the NF-L antibody labels neuronal cells and their processes. Right: Western blot analysis of whole tissue lysates using mouse antibody to GFAP (1:2,000, green). [1] protein standard , [2] rat brain, [3] rat spinal cord, [4] mouse brain, [5] mouse spinal cord. The strong band at about 50 kDa corresponds to the GFAP protein.

    Citations & References

  • Specific References Kawabe K et al. (2017) Transglutaminases Derived from Astrocytes Accelerate Amyloid _ Aggregation. Neurochem Res. [Epub ahead of print]. Application: ICC (cultured rat astrocytes).

    Nagai T et al. (2017) Development of an in situ evaluation system for neural cells using extracellular matrix-modeled gel culture. J Biosci Bioeng. 124(4):430-8. Application: IF (artificial gel matrix).

    Kawabe T et al. (2017) Microglia Endocytose Amyloid _ Through the Binding of Transglutaminase 2 and Milk Fat Globule EGF Factor 8 Protein. Neurochem Res. [Epub ahead of print] Application: ICC (cultured astrocytes).

    Takano K et al. (2017) Inhibition of Gap Junction Elevates Glutamate Uptake in Cultured Astrocytes. Neurochem Res. [Epub ahead of print] Application: ICC (cultured astrocytes).
  • General References Reeves S.A, et al. Proc. Natl. Acad. Sci. U.S.A. 86:5178-5182(1989).
    2. Brenner M, et al. Brain Res. Mol. Brain Res. 7:277-286(1990).
    Isaacs A, et al. Genomics 51:152-154(1998).
    Ota T, et al. Nat. Genet. 36:40-45(2004).
    Nielsen A.L, et al. J. Biol. Chem. 277:29983-29991(2002).
    Singh R, et al. Genomics 82:185-193(2003).
    Brenner M, et al. Nat. Genet. 27:117-120(2001).
    Brockmann K, et al. Eur. Neurol. 50:100-105(2003).
    Stumpf E, et al. Arch. Neurol. 60:1307-1312(2003).
    Sawaishi Y, et al. Neurology 58:1541-1543(2002).
    Aoki Y, et al. Neurosci. Lett. 312:71-74(2001).